Table 1. Clinical traits of HCC patients in TCGA and ICGC database.
| Characteristics | TCGA-LIHC | LIRI-JP |
|---|---|---|
| Survival status | ||
| Alive | 248 (66.0%) | 269 (68.3%) |
| Dead | 128 (34.0%) | 79 (20.1%) |
| Age (mean, SD) | 59.5 (13.5) | 64.7 (11.1) |
| Gender | ||
| Female | 122 (32.4%) | 95 (24.1%) |
| Male | 254 (67.6%) | 299 (75.9%) |
| Grade | ||
| G1 | 55 (14.6%) | 59 (15.0%) |
| G2 | 180 (47.9%) | 162 (41.1%) |
| G3 | 123 (32.7%) | 77 (19.5%) |
| G4 | 13 (3.5%) | 43 (10.9%) |
| Unknown | 5 (1.3%) | 53 (13.5%) |
| T stage | ||
| T1 | 185 (49.2%) | NA |
| T2 | 94 (25.0%) | NA |
| T3 | 81 (21.5%) | NA |
| T4 | 13 (3.5%) | NA |
| Unknown | 3 (0.8%) | NA |
| M stage | ||
| M0 | 272 (72.3%) | NA |
| M1 | 4 (1.1%) | NA |
| MX | 100 (26.6%) | NA |
| N stage | ||
| N0 | 257 (68.4%) | NA |
| N1 | 4 (1.1%) | NA |
| NX | 114 (30.3%) | NA |
| Unknown | 1 (0.3%) | NA |
HCC, hepatocellular carcinoma; TCGA, The Cancer Genome Atlas; ICGC, international cancer genome consortium. LIHC, liver hepatocellular carcinoma; LIRI-JP, liver cancer RIKEN Japan.